Intellia Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $269.9M | $57.2M |
| FY2020 | — | $527.1M | $160.0M |
| FY2021 | — | $1.04B | $123.4M |
| FY2022 | — | $1.24B | $523.5M |
| FY2023 | — | $1.05B | $226.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $269.9M | $57.2M |
| FY2020 | — | $527.1M | $160.0M |
| FY2021 | — | $1.04B | $123.4M |
| FY2022 | — | $1.24B | $523.5M |
| FY2023 | — | $1.05B | $226.7M |